The prevalence of TPO antibodies 3 months after acute infection was 15.7% in COVID-19 survivors compared to 7.7% in age- and sex-matched controls, suggesting a role for COVID-19 in eliciting thyroid autoimmunity (54). This evidence concerns the gene TPO and autoimmune thyroid disease.